Rita Vanbever

Cited by

	All	Since 2019
Citations	7740	2306
h-index	45	25
i10-index	75	49

500

250

125

375

199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202431 54 112 102 91 149 137 190 196 241 285 320 287 289 299 339 303 355 384 381 400 415 376 394 483 457 414 182

Public access

View all

13 articles

6 articles

available

not available

Based on funding mandates

Co-authors

Veronique PreatProfesseur, Université catholique de LouvainVerified email at uclouvain.be
Robert LangerMassachusetts Institute of TechnologyVerified email at mit.edu
Lison Dominiqueprofessor of Toxicology, Université catholique de Louvain, BrusselsVerified email at uclouvain.be
Jean-Christophe RenauldUCLouvainVerified email at uclouvain.be
Teresinha LealUniversité Catholique de LouvainVerified email at uclouvain.be
Didier CATALDOUniversité de LiègeVerified email at uliege.be
Donatienne Tytecachercheur qualifiée FRS-FNRSVerified email at uclouvain.be
Julie DucreuxChargé de Recherche, Université catholique de LouvainVerified email at uclouvain.be
Francois HuauxLouvain centre for Toxicology and Applied Pharmacology, Université catholique de LouvainVerified email at uclouvain.be
Jennifer FiegelProfessor, University of IowaVerified email at engineerweb.org
Carsten EhrhardtTrinity College DublinVerified email at tcd.ie
John S PattonKindeva Drug DeliveryVerified email at kindevadd.com
Fabrice BureauUniversity of LiegeVerified email at uliege.be
Hadi GoldansazUnivesité catholique de LouvainVerified email at uclouvain.be
Frédérick RaphaëluclouvainVerified email at uclouvain.be
Giulio G MuccioliProfessor, UCLouvain, Louvain Drug Research Institute, BPBL Research GroupVerified email at uclouvain.be
Philippe HantsonUniversité catholique de Louvain, BelgiumVerified email at uclouvain.be
Pierre WallemacqCliniques universitaires St Luc, Université catholique de LouvainVerified email at uclouvain.be
Christine Dupont-GillainProfessor and researcher, physical chemistry of biointerfacesVerified email at uclouvain.be
Cameron AlexanderSchool of Pharmacy, University of NottinghamVerified email at nottingham.ac.uk

Rita Vanbever

Université catholique de Louvain

Verified email at uclouvain.be - Homepage

Drug delivery


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Preparation of particles for inhalation DA Edwards, RS Langer, R Vanbever, J Mintzes, J Wang, D Chen US Patent 5,985,309, 1999	690	1999
Skin electroporation for transdermal and topical delivery AR Denet, R Vanbever, V Préat Advanced drug delivery reviews 56 (5), 659-674, 2004	670	2004
Formulation and physical characterization of large porous particles for inhalation R Vanbever, JD Mintzes, J Wang, J Nice, D Chen, R Batycky, R Langer, ... Pharmaceutical research 16, 1735-1742, 1999	420	1999
Delivery strategies for sustained drug release in the lungs C Loira-Pastoriza, J Todoroff, R Vanbever Advanced drug delivery reviews 75, 81-91, 2014	401	2014
Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance C Bosquillon, C Lombry, V Preat, R Vanbever Journal of controlled release 70 (3), 329-339, 2001	378	2001
The particle has landed—characterizing the fate of inhaled pharmaceuticals JS Patton, JD Brain, LA Davies, J Fiegel, M Gumbleton, KJ Kim, ... Journal of aerosol medicine and pulmonary drug delivery 23 (S2), S-71-S-87, 2010	275	2010
Transdermal delivery of metoprolol by electroporation R Vanbever, N Lecouturier, V Préat Pharmaceutical research 11, 1657-1662, 1994	215	1994
Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats C Bosquillon, V Préat, R Vanbever Journal of Controlled Release 96 (2), 233-244, 2004	203	2004
Introduction of modifying agents into skin by electroporation JC Weaver, T Chen, C Cullander, R Guy, RS Langer, TE Zewert, ... US Patent 5,911,223, 1999	203	1999
In vivo efficacy and safety of skin electroporation R Vanbever, V Preat Advanced drug delivery reviews 35 (1), 77-88, 1999	174	1999
Transdermal delivery of fentanyl by electroporation I. Influence of electrical factors R Vanbever, E Le Boulengé, V Préat Pharmaceutical research 13, 559-565, 1996	168	1996
Large porous particles for sustained protection from carbachol-induced bronchoconstriction in guinea pigs A Ben-Jebria, D Chen, ML Eskew, R Vanbever, R Langer, DA Edwards Pharmaceutical research 16, 555-561, 1999	165	1999
Fate of nanomedicines in the lungs J Todoroff, R Vanbever Current Opinion in Colloid & Interface Science 16 (3), 246-254, 2011	156	2011
Aerosolization properties, surface composition and physical state of spray-dried protein powders C Bosquillon, PG Rouxhet, F Ahimou, D Simon, C Culot, V Préat, ... Journal of Controlled Release 99 (3), 357-367, 2004	154	2004
Alveolar macrophages are a primary barrier to pulmonary absorption of macromolecules C Lombry, DA Edwards, V Préat, R Vanbever American Journal of Physiology-Lung Cellular and Molecular Physiology 286 (5 …, 2004	152	2004
Transdermal drug delivery RH Guy, J Hadgraft M. Dekker, 2003	135	2003
Preclinical models for pulmonary drug delivery CA Fernandes, R Vanbever Expert opinion on drug delivery 6 (11), 1231-1245, 2009	132	2009
Systemic delivery of parathyroid hormone (1-34) using inhalation dry powders in rats V Codrons, F Vanderbist, RK Verbeeck, M Arras, D Lison, V Préat, ... Journal of pharmaceutical sciences 92 (5), 938-950, 2003	131	2003
Biopotential measurement including electroporation of tissue surface JC Weaver, U Pliquett, R Vanbever, TR Gowrishankar, TE Zewert US Patent 6,085,115, 2000	123	2000
Transdermal delivery of fentanyl: rapid onset of analgesia using skin electroporation R Vanbever, G Langers, S Montmayeur, V Preat Journal of controlled release 50 (1-3), 225-235, 1998	106	1998

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors